BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT07176650-completion@plaintrial.com
DTSTAMP:20261027T110404Z
DTSTART;VALUE=DATE:202612
SUMMARY:Phase I Clinical Study To Evaluate Pharmacokinetic Profile\, Safety
 \, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY®
  (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresec
 table Hepatocellular Carcinoma — estimated completion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT07176650
URL:https://plaintrial.com/trial/NCT07176650
END:VEVENT
END:VCALENDAR